Cerezyme Prices, Coupons and Patient Assistance Programs
Cerezyme (imiglucerase) is a member of the lysosomal enzymes drug class and is commonly used for Gaucher Disease and Thrombocytopenia.
Cerezyme Prices
The cost for Cerezyme intravenous powder for injection 400 units is around $1,758 for a supply of 1 powder for injection, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
This Cerezyme price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Intravenous Powder For Injection
| Quantity | Per unit | Price |
|---|---|---|
| 1 | $1,758.03 | $1,758.03 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardPlease note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Cerezyme Coupons and Rebates
Cerezyme offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Cerezyme CareConnectPSS Co-Pay Assistance Program: Eligible commercially insured patients may receive assistance through the program to pay for eligible, out-of-pocket expenses such as co-pays, coinsurance, and deductibles; for additional information contact the program at 800-745-4447, option 3.
| Applies to: | Cerezyme |
| Number of uses: | Contact the program |
Cerezyme Sanofi Genzyme Co-Pay Assistance Program: Program will cover 100% of out-of-pocket costs for eligible commercially insured patients; for additional information contact the program at 800-745-4447, option 3.
| Applies to: | Cerezyme |
| Number of uses: | 12 times within calendar year |
Patient Assistance Programs for Cerezyme
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
Provider: Patient Access Network Foundation (PAN)
Elligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
- Cerezyme (imiglucerase) Injection
Provider: Sanofi Genzyme Charitable Access Program
Elligibility requirements:- Determined case by case
- Not disclosed
- FDA-approved diagnosis
- Must be treated by US licensed healthcare provider
- Resources for HEALTHCARE PROFESSIONALS ONLY. Qualified individuals with Lysosomal Storage Disorders (Gaucher Disease, Fabry Disease, MPS1 and Pompe Disease) whose physicians have recommended treatment may be eligible for this program. This is considered a temporary funding program. Patients and their families are expected to continue exploring alternative resources with the assistance of a Sanofi Genzyme case manager.
Applicable drugs:
- Cerezyme (imiglucerase) Injection
More about Cerezyme (imiglucerase)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Interactions
- En Español
- 1 Review
- Drug class: lysosomal enzymes
- FDA Alerts (1)
